EGETIS THERAPEUTICS AB financial statements, including revenue, expenses, profit, and loss

The total revenue of EGTX for the last quarter is 13.90 M SEK, and it's 14.88% higher compared to the previous quarter. The net income of Q2 24 is -71.90 M SEK.